Facial Hyperpigmentation during Imatinib Therapy for Gastrointestinal Stromal Tumor-Reference-Cited by-同舟云学术

Facial Hyperpigmentation during Imatinib Therapy for Gastrointestinal Stromal Tumor

Published:2014-05 Issue:3 Volume:69 Page:245-247
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Hamza Imene,Gaies Emna,Kastalli Sarrah,Daghfous Riadh,El Aidli Sihem

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference25 articles.

1. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST);Hochhaus;Ann Hematol,2004

2. Use of imatinib mesylate in gastrointestinal stromal tumours: Pan-Birmingham Cancer Network experience;Wong;Clin Oncol,2008

3. STI571: a paradigm of new agents for cancer therapeutics;Mauro;J Clin Oncol,2002

4. Indications for imatinib mesylate therapy and clinical management;Guilhot;Oncologist,2004

5. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced Pigmentation: A Review;Drugs;2024-08-01

2. Oncologist-patient conflict regarding imatinib-induced pigmentation: A case report and literature review;National Journal of Pharmacology and Therapeutics;2024-05

3. Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis;Journal of the American Academy of Dermatology;2017-11

4. Managing Cutaneous Side Effects From Targeted Molecular Inhibitors for Melanoma and Nonmelanoma Skin Cancer;Dermatologic Surgery;2016-01

5. Pigmentation palatine associée à un traitement par imatinib;Médecine Buccale Chirurgie Buccale;2014-10